Business Context and Reporting Period
This Form 8-K is a current report filed by AptarGroup, Inc. on September 4, 2026. The filing addresses Item 5.02 regarding the departure of a senior officer and the appointment of an interim replacement.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and personnel changes.
Material Changes
- Resignation: Aditya J. Gandhi, Vice President and Chief Accounting Officer, resigned effective September 11, 2026, to pursue another opportunity outside the greater Chicago area.
- Appointment: Daniel Ackerman was appointed Senior Vice President and Interim Chief Accounting Officer, effective September 11, 2026.
- Reasoning: The resignation was not the result of any disagreement with the Company regarding operations, policies, or practices.
Guidance, Outlook, and Management Commentary
There is no financial guidance, outlook, or discussion of risks and contingencies in this filing. Management commentary is limited to the transition of the Chief Accounting Officer role. Mr. Ackerman, who previously held the Chief Accounting Officer role from August 2024 to June 2026, will resume the position and report to Vanessa Kanu, Executive Vice President and Chief Financial Officer.
Investor Verification Checklist
- Confirm the effective date of the leadership transition (September 11, 2026).
- Verify the background of the interim appointee, Daniel Ackerman, including his prior tenure as Chief Accounting Officer and recent role as Senior Vice President, Finance for Aptar Pharma.
- Monitor future filings for the appointment of a permanent Chief Accounting Officer.
- Review subsequent financial reports to ensure no undisclosed disagreements or accounting issues arose from the departure.